PL2699575T3 - Triazolopirydyny - Google Patents

Triazolopirydyny

Info

Publication number
PL2699575T3
PL2699575T3 PL12721779T PL12721779T PL2699575T3 PL 2699575 T3 PL2699575 T3 PL 2699575T3 PL 12721779 T PL12721779 T PL 12721779T PL 12721779 T PL12721779 T PL 12721779T PL 2699575 T3 PL2699575 T3 PL 2699575T3
Authority
PL
Poland
Prior art keywords
triazolopyridines
Prior art date
Application number
PL12721779T
Other languages
English (en)
Inventor
Volker Schulze
Dirk Kosemund
Antje Margret Wengner
Gerhard Siemeister
Detlef Stöckigt
Philip Lienau
Hartmut Schirok
Hans Briem
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of PL2699575T3 publication Critical patent/PL2699575T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL12721779T 2011-04-21 2012-04-16 Triazolopirydyny PL2699575T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP11163342 2011-04-21
EP11167872 2011-05-27
EP12721779.2A EP2699575B1 (en) 2011-04-21 2012-04-16 Triazolopyridines
PCT/EP2012/056914 WO2012143329A1 (en) 2011-04-21 2012-04-16 Triazolopyridines

Publications (1)

Publication Number Publication Date
PL2699575T3 true PL2699575T3 (pl) 2015-08-31

Family

ID=46124297

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12721779T PL2699575T3 (pl) 2011-04-21 2012-04-16 Triazolopirydyny

Country Status (39)

Country Link
US (1) US20140120087A1 (pl)
EP (1) EP2699575B1 (pl)
JP (1) JP5989091B2 (pl)
KR (1) KR20140025470A (pl)
CN (1) CN103608350B (pl)
AP (1) AP3491A (pl)
AR (1) AR086191A1 (pl)
AU (1) AU2012244859B2 (pl)
CA (1) CA2833657A1 (pl)
CL (1) CL2013003044A1 (pl)
CO (1) CO6801751A2 (pl)
CR (1) CR20130539A (pl)
CY (1) CY1116439T1 (pl)
DK (1) DK2699575T3 (pl)
DO (1) DOP2013000244A (pl)
EA (1) EA023766B1 (pl)
EC (1) ECSP13013011A (pl)
ES (1) ES2539265T3 (pl)
GT (1) GT201300254A (pl)
HR (1) HRP20150517T1 (pl)
HU (1) HUE025496T2 (pl)
IL (1) IL228704A0 (pl)
JO (1) JO3040B1 (pl)
MA (1) MA35049B1 (pl)
ME (1) ME02143B (pl)
MX (1) MX348783B (pl)
MY (1) MY164939A (pl)
PE (1) PE20141351A1 (pl)
PH (1) PH12013502169A1 (pl)
PL (1) PL2699575T3 (pl)
PT (1) PT2699575E (pl)
RS (1) RS54044B1 (pl)
SA (1) SA112330466B1 (pl)
SG (1) SG194003A1 (pl)
SI (1) SI2699575T1 (pl)
TW (1) TWI558703B (pl)
UY (1) UY34034A (pl)
WO (1) WO2012143329A1 (pl)
ZA (1) ZA201308707B (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013027096A2 (pt) 2011-04-21 2016-12-27 Gilead Sciences Inc compostos de benzotiazol e seu uso farmacêutico
UA112096C2 (uk) * 2011-12-12 2016-07-25 Байєр Інтеллектуал Проперті Гмбх Заміщені триазолопіридини та їх застосування як інгібіторів ttk
US9284323B2 (en) 2012-01-04 2016-03-15 Gilead Sciences, Inc. Naphthalene acetic acid derivatives against HIV infection
WO2013103724A1 (en) 2012-01-04 2013-07-11 Gilead Sciences, Inc. 2- (tert - butoxy) -2- (7 -methylquinolin- 6 - yl) acetic acid derivatives for treating aids
CN104284896B (zh) 2012-03-14 2016-06-01 拜耳知识产权有限责任公司 取代的咪唑并哒嗪
CA2878481A1 (en) 2012-07-10 2014-01-16 Bayer Pharma Aktiengesellschaft Method for preparing substituted triazolopyridines
WO2014020041A1 (en) 2012-08-02 2014-02-06 Bayer Pharma Aktiengesellschaft Combinations for the treatment of cancer
WO2014020043A1 (en) 2012-08-02 2014-02-06 Bayer Pharma Aktiengesellschaft Combinations for the treatment of cancer
WO2014195274A1 (en) * 2013-06-07 2014-12-11 Bayer Pharma Aktiengesellschaft Substituted triazolopyridines
JP2016527193A (ja) * 2013-06-07 2016-09-08 バイエル・ファルマ・アクティエンゲゼルシャフト 置換トリアゾロピリジン
SG11201509351UA (en) * 2013-06-10 2015-12-30 Bayer Pharma AG Novel compounds for the treatment of cancer
HK1219879A1 (zh) * 2013-06-11 2017-04-21 Bayer Pharma Aktiengesellschaft 用於治疗癌症的包含mps-1激酶抑制剂和有丝分裂抑制剂的组合
RS56034B1 (sr) * 2013-06-11 2017-09-29 Bayer Pharma AG Derivati prolekova supstituisanih triazolopiridina
EP2860177A3 (en) 2013-09-20 2015-06-10 Bayer Intellectual Property GmbH Synthesis of functionalized arenes
FI3283642T3 (fi) 2015-04-17 2024-01-11 Crossfire Oncology Holding B V Prognostisia biomarkkereita ttk-inhibiittorikemoterapiaan
CN109963854B (zh) * 2017-03-16 2022-04-12 江苏恒瑞医药股份有限公司 杂芳基并[4,3-c]嘧啶-5-胺类衍生物、其制备方法及其在医药上的应用
NZ780966A (en) 2019-04-18 2026-02-27 Univ Johns Hopkins Substituted 2-amino-pyrazolyl-[1,2,4]triazolo[1,5a] pyridine derivatives and use thereof
JP2022539208A (ja) 2019-07-03 2022-09-07 スミトモ ファーマ オンコロジー， インコーポレイテッド チロシンキナーゼ非受容体１（ｔｎｋ１）阻害剤およびその使用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US5011472A (en) 1988-09-06 1991-04-30 Brown University Research Foundation Implantable delivery system for biological factors
MX2007001943A (es) 2004-08-17 2007-05-09 Galderma Res & Dev Nuevos compuestos biaromaticos activadores de los receptores del tipo receptor activado del proliferador de peroxisoma (ppar) y su uso en composiciones cosmeticas o farmaceuticas.
JP5336375B2 (ja) * 2006-08-30 2013-11-06 セルゾーム リミテッド キナーゼ阻害剤としてのトリアゾール誘導体
US8053574B2 (en) 2007-07-18 2011-11-08 Novartis Ag Organic compounds
MX2010002115A (es) 2007-08-23 2010-06-01 Aztrazeneca Ab 2-anilinopurin-8-onas como inhibidores de ttk/mps1 para el tratamiento de trastornos .proliferativos.
CA2691448A1 (en) * 2007-08-31 2009-03-05 Dominique Swinnen Triazolopyridine compounds and their use as ask inhibitors
GB0719803D0 (en) 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
MX2010005700A (es) * 2007-11-27 2010-06-11 Cellzome Ltd Amino triazoles como inhibidores pi3k.
SG173610A1 (en) 2009-02-13 2011-09-29 Fovea Pharmaceuticals Sa [1, 2, 4] triazolo [1, 5 -a] pyridines as kinase inhibitors
CN102413831B (zh) 2009-04-29 2014-06-04 拜耳知识产权有限责任公司 取代的咪唑并喹喔啉
CA2772790C (en) 2009-09-04 2017-06-27 Benjamin Bader Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
EP2343297A1 (en) 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridines
UY33452A (es) * 2010-06-16 2012-01-31 Bayer Schering Pharma Ag Triazolopiridinas sustituidas

Also Published As

Publication number Publication date
AU2012244859A1 (en) 2013-10-31
EA023766B1 (ru) 2016-07-29
AU2012244859B2 (en) 2017-06-08
IL228704A0 (en) 2013-12-31
TW201245194A (en) 2012-11-16
AR086191A1 (es) 2013-11-27
TWI558703B (zh) 2016-11-21
HUE025496T2 (en) 2016-04-28
HK1190398A1 (zh) 2014-07-04
EP2699575B1 (en) 2015-03-25
DK2699575T3 (da) 2015-06-22
CO6801751A2 (es) 2013-11-29
CA2833657A1 (en) 2012-10-26
JP2014511887A (ja) 2014-05-19
ES2539265T3 (es) 2015-06-29
SI2699575T1 (sl) 2015-10-30
PT2699575E (pt) 2015-07-29
JP5989091B2 (ja) 2016-09-07
NZ616456A (en) 2015-09-25
MY164939A (en) 2018-02-15
EA201301181A1 (ru) 2014-08-29
WO2012143329A1 (en) 2012-10-26
MX348783B (es) 2017-06-28
ME02143B (me) 2015-10-20
SG194003A1 (en) 2013-11-29
ECSP13013011A (es) 2013-12-31
RS54044B1 (sr) 2015-10-30
AP2013007182A0 (en) 2013-10-31
AP3491A (en) 2015-12-31
CN103608350A (zh) 2014-02-26
GT201300254A (es) 2015-09-01
EP2699575A1 (en) 2014-02-26
CR20130539A (es) 2013-12-04
HRP20150517T1 (hr) 2015-06-19
US20140120087A1 (en) 2014-05-01
KR20140025470A (ko) 2014-03-04
PE20141351A1 (es) 2014-11-01
DOP2013000244A (es) 2014-03-16
ZA201308707B (en) 2016-07-27
SA112330466B1 (ar) 2015-09-28
CN103608350B (zh) 2015-11-25
CL2013003044A1 (es) 2014-05-02
MA35049B1 (fr) 2014-04-03
JO3040B1 (ar) 2016-09-05
PH12013502169A1 (en) 2014-01-13
CY1116439T1 (el) 2017-02-08
MX2013012289A (es) 2013-11-21
UY34034A (es) 2012-11-30

Similar Documents

Publication Publication Date Title
DK3505720T3 (en) Cementering under styret tryk
DK3424953T3 (en) Terapeutiske antistoffer
DK2691417T4 (en) Antistof fc-varianter
AP3491A (en) Triazolopyridines
EP2754063A4 (en) EXTENSIBILITY OF THE SMB2 PROTOCOL
EP2723631A4 (en) QUADFOILER
EP2776444A4 (en) dihydropteridinones
AP2014007621A0 (en) 2-Thiopyrimidinones
DK2770906T3 (en) Applanationstonometer
IL227377A0 (en) Combinations
GB201109024D0 (en) Can
GB201101727D0 (en) Obuoy
GB201100001D0 (en) TidySqueeze2
AU5026P (en) Goldstrike Agapanthus inapertus
AU4540P (en) BUNNAN Baloskion tetraphyllum
AU5031P (en) BESYS Beschorneria yuccoides
GB201109627D0 (en) Easy clear
AU340282S (en) Can
GB201115238D0 (en) Pit-stop easy
AP00723S1 (en) Autorickshaw
GB201102519D0 (en) Mirrorcane
GB201102635D0 (en) Panalock
GB201102013D0 (en) Aimspray easyreach
GB201102052D0 (en) Stabilearner
GB201102066D0 (en) Scottscraper